Measuring impact of comorbidities in different trusts (MIC)
Research type
Research Study
Full title
Non-interventional exploratory study to assess perception of comorbidities in patients with inflammatory arthritis
IRAS ID
234976
Contact name
Gouri Mani Koduri
Contact email
Sponsor organisation
Southend University Hospital NHS Foundation Trust
Duration of Study in the UK
1 years, 0 months, 0 days
Research summary
Comorbidity is one of the most important issues facing health systems and the single disease approach is unable to address this problem appropriately. Number of people with comorbidities is set to increase in England from 1.9 million in 2008 to 2.9 million by 2018. These patients are likely to face complex physical,social and emotional problems and are more likely to have psychological problems.Comorbidity might delay diagnosis and influence treatment decisions, obscure survival and outcomes. Patients with multisystem rheumatic diseases are at increased risk of comorbidities. Rheumatoid arthritis is known to have a high disease burden on patients, families and society. It is estimated that in England the annual direct healthcare costs of RA are approximately €780 million per year and the indirect costs related to work disability up to €6.75 billion. Comorbidity is associated with high mortality, poor quality of life and higher healthcare costs. Comorbidity can be associated with poor therapeutic adherence and risks. Better management of people with comorbidities is a key challenge.There are various studies on Professional concepts of Comorbidity but not much on patient’s perspective on comorbidities. Little is yet known about how patients with multiple conditions, view their illness. There is a need to understand patient perspective, their experience of comorbidities in order to complement the professional perspective and ensure that care is truly patient centred.
The aim of this project is to explore patients experience and views about comorbidities. Secondly, to explore patients perceptions on disease causation and the impact of polypharmacy. Finally to assess the needs, awareness and barriers to education or self-management in patients with comorbidities.Outcomes of this project could be used to plan local services.It may also help to develop public health
services, mobile apps, or self-monitoring devices. This study will be conducted in three NHS Trusts using questionnaires and interviews and will last for 12 months.REC name
London - Bromley Research Ethics Committee
REC reference
18/LO/0409
Date of REC Opinion
11 May 2018
REC opinion
Further Information Favourable Opinion